Commercial
Advanced Search
  
  
  
  
  
  
  
  
  
  
  
News & AnnouncementsExpanded Coverage of Pneumococcal 15-valent Conjugate Vaccine for Independence Commercial Members9/13/2022
News & AnnouncementsCoverage of the COVID-19 Vaccination for Independence Commercial Members (Retroactively effective to August 31, 2022, Issued September 27, 2022)9/27/2022
News & Announcements10/01/2022 CPT & HCPCS Quarterly Code Update Coverage Determinations for Commercial Products9/30/2022
NotificationsMedical and Surgical Treatment of Temporomandibular Joint Disorder07.08.03h9/9/2022 10:00 AM10/10/20229/9/2022Medical Necessity Criteria;General Description, Guidelines, or Informational Update
NotificationsEculizumab (Soliris®) and Related Biosimilars, Ravulizumab-cwvz (Ultomiris®)08.00.84i9/19/2022 1:00 PM10/17/20229/19/2022Medical Necessity Criteria;General Description, Guidelines, or Informational Update
NotificationsPneumatic Compression Therapy Devices05.00.01n9/23/2022 9:00 AM10/24/20229/23/2022Coverage and/or Reimbursement Position;Medical Necessity Criteria;Medical Coding;General Description, Guidelines, or Informational Update
NotificationsChemical Peels11.08.08h9/26/2022 2:00 PM12/26/20229/26/2022Coverage and/or Reimbursement Position
NotificationsChimeric Antigen Receptor (CAR) Therapy08.01.43k9/28/2022 9:00 AM10/31/20229/28/2022Medical Necessity Criteria
Updated PoliciesDurable Medical Equipment (DME) and Consumable Medical Supplies05.00.21z8/5/2022 2:00 PM9/5/20229/6/2022Coverage and/or Reimbursement Position;Medical Coding
Updated PoliciesNebulizers and Inhalation Solutions05.00.15s8/5/2022 9:00 AM9/5/20229/6/2022Medical Necessity Criteria
Updated PoliciesMusculoskeletal Services (Independence)00.01.66f9/11/20229/11/2022Coverage and/or Reimbursement Position;Medical Coding
Updated PoliciesSleep Disorder Testing and Positive Airway Pressure Therapy Services and Supplies07.03.05y9/11/20229/11/2022General Description, Guidelines, or Informational Update
Updated PoliciesHospital Beds and Accessories05.00.56k8/12/2022 9:00 AM9/12/20229/12/2022General Description, Guidelines, or Informational Update
Updated PoliciesHigh-Technology Radiology Services09.00.46al9/11/20229/12/2022Medical Necessity Criteria
Updated PoliciesAqueous Shunts, Microstents, Viscocanalostomy, and Canaloplasty for the Treatment of Glaucoma11.05.16k6/20/2022 12:00 PM9/19/20229/19/2022Medical Coding
Updated PoliciesCorneal Pachymetry Using Ultrasound07.13.07l6/20/2022 12:00 PM9/19/20229/19/2022Medical Coding
Updated PoliciesSebelipase alfa (Kanuma®)08.01.28e9/26/20229/26/2022Medical Necessity Criteria
Updated PoliciesRituximab (Rituxan®) Infusion and Related Biosimilars, and Rituximab/Hyaluronidase Human for Subcutaneous Injection (Rituxan Hycela®)08.00.50aa10/1/20229/30/2022Coverage and/or Reimbursement Position;Medical Necessity Criteria;Medical Coding;General Description, Guidelines, or Informational Update
Reissue PoliciesFull-Body Monoplace or Multiplace Chamber Hyperbaric Oxygen Therapy07.00.03o1/31/20229/7/20229/7/2022
Reissue PoliciesDay Rehabilitation10.00.02c1/13/20209/7/20229/7/2022
Reissue PoliciesOsteogenic Stimulators (non-invasive, invasive/semi-invasive, electrical and ultrasound)05.00.811/10/20219/7/20229/7/2022
Reissue PoliciesModifier 50: Bilateral Procedure03.00.05t7/1/20229/7/20229/7/2022
Reissue PoliciesModifier 62: Two Surgeons00.10.11t7/1/20229/7/20229/7/2022
Reissue PoliciesModifiers 26 (Professional Component) and TC (Technical Component)03.00.20o7/1/20229/7/20229/8/2022
Reissue PoliciesEndovascular Grafts for Abdominal Aortic Aneurysms (AAA), Aortic-Iliac Aneurysms, and Infrarenal Aortic Aneurysms11.02.10p1/1/20229/21/20229/21/2022
Reissue PoliciesSpeech Therapy10.06.01l1/1/20209/21/20229/21/2022
Reissue PoliciesImmune Prophylaxis for Respiratory Syncytial Virus (RSV)08.00.22o9/13/20219/21/20229/22/2022
Reissue PoliciesTranscatheter Closure of Cardiac Septal Defects11.02.11g11/17/20179/21/20229/22/2022
Reissue PoliciesProcedures for the Treatment of Acne11.08.29e10/1/20169/21/20229/22/2022
Coding UpdateBrentuximab Vedotin (Adcetris®)08.01.13h10/1/20229/30/2022
Coding UpdateFilgrastim  (Neupogen ®) and Related Biosimilars, and tbo-filgrastim (Granix ®)08.01.73c10/1/20229/30/2022
Coding UpdateCoagulation Factors 08.00.92ae10/1/20229/30/2022
Coding UpdateTebentafusp-tebn (Kimmtrak®)08.01.85b10/1/20229/30/2022
Coding UpdateAmbulatory Electrocardiography (AECG) Monitoring and Mobile Cardiac Outpatient Telemetry (MCOT) Monitoring07.02.21i10/1/20229/30/2022
Coding UpdateAutomatic External Cardioverter Defibrillators (Wearable and Nonwearable)05.00.29m10/1/20229/30/2022
Coding UpdateCardiac Rehabilitation (CR) and Intensive Cardiac Rehabilitation (ICR) Programs10.01.01o10/1/20229/30/2022
Coding UpdateCatheter Ablation of Cardiac Arrhythmias11.02.06o10/1/20229/30/2022
Coding UpdateEndovascular Stent-Graft Repair of Thoracic Aortic Aneurysms and Nonaneurysmal Lesions11.02.17h10/1/20229/30/2022
Coding UpdateSubcutaneous Implantable Cardioverter Defibrillator (S-ICD) for Treating Life-threatening Ventricular Tachyarrhythmia05.00.77c10/1/20229/30/2022
Coding UpdateTranscatheter Closure of Cardiac Septal Defects11.02.11h10/1/20229/30/2022
Coding UpdateWireless Capsule Endoscopy (WCE) as a Diagnostic Technique in Disorders of the Small Bowel, Esophagus, and Colon07.05.02p10/1/20229/30/2022
Coding UpdateHome-Based Sleep Studies07.03.01b10/1/20229/30/2022
Coding UpdateAnesthesia Services for Epidural, Paravertebral Facet and Sacroiliac Joint Injections for Spinal Joint Management01.00.12a10/1/20229/30/2022
Coding UpdateEsophagogastroduodenoscopy (EGD) and Endoscopic Retrograde Cholangiopancreatography (ERCP)07.02.22c10/1/20229/30/2022
Coding UpdateInfliximab and Related Biosimilars08.00.34r10/1/20229/30/2022
Coding UpdateBevacizumab (Avastin®) and Related Biosimilars For Oncologic Use08.00.66r10/1/20229/30/2022
Coding UpdateBotulinum Toxin Agents08.00.26z10/1/20229/30/2022
Coding UpdateAutonomic Nervous System Testing07.03.23f10/1/20229/30/2022
Coding UpdateWound Care: Skin Substitutes for the Treatment of Burns and Chronic, Non-Healing Wounds11.08.20ad10/1/20229/30/2022
Coding UpdateElectromyography (EMG) Studies: Needle EMG, Surface EMG (SEMG)07.03.09t10/1/20229/30/2022
Coding UpdateImmune Globulin Intravenous (IVIG), Subcutaneous (SCIG)08.00.13ae10/1/20229/30/2022
Coding UpdatePembrolizumab (Keytruda®)08.01.63c10/1/20229/30/2022
Coding UpdateNerve Conduction Studies (NCS) and Related Electrodiagnostic Studies07.03.18s10/1/20229/30/2022
Coding UpdateCoverage of Anticancer Prescription Oral and Injectable Drugs and Biologics and Supportive Agents08.01.08j10/1/20229/30/2022
Coding UpdateHigh-Frequency Chest Wall Oscillation Devices05.00.14o10/1/20229/30/2022
Coding UpdateGonadotropin-Releasing Hormone Agonist (Eligard®, Fensolvi®, Lupron Depot®)08.01.33g10/1/20229/30/2022
Coding UpdateEculizumab (Soliris®) and Related Biosimilars, Ravulizumab-cwvz (Ultomiris®)08.00.84i10/1/20229/30/2022
Coding UpdateSutimlimab-jome (Enjaymo)08.01.87a10/1/20229/30/2022
Coding UpdateFetal Surgery11.00.03k10/1/20229/30/2022
Coding UpdateElective Abortion11.06.02j10/1/20229/30/2022
Coding UpdateHematopoietic Stem Cell Transplantation (Bone Marrow Transplant)11.07.01x10/1/20229/30/2022
Coding Updatenivolumab and relatlimab-rmbw (Opdualag™) 08.01.94a10/1/20229/30/2022
Coding UpdateCranial Electrotherapy Stimulation05.00.80b10/1/20229/30/2022
Coding UpdateLanreotide (Somatuline® Depot)08.01.40e10/1/20229/30/2022